- Home
- XNCR vs HCI Comparison
XNCR vs HCI Comparison
Compare XNCR & HCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XNCR | HCI |
|---|---|---|
| Founded | 1997 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | 2013 | 2008 |
Fundamental Metrics
Financial Performance| Metric | XNCR | HCI |
|---|---|---|
| Price | $24.77 | $181.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 5 |
| Target Price | $31.42 | ★ $241.67 |
| AVG Volume (30 Days) | ★ 1.0M | 105.6K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 0.92% |
| EPS Growth | 65.36 | ★ 155.57 |
| EPS | N/A | ★ 11.05 |
| Revenue | $125,576,000.00 | ★ $900,946,000.00 |
| Revenue This Year | $14.05 | $9.99 |
| Revenue Next Year | N/A | $6.47 |
| P/E Ratio | ★ N/A | $15.97 |
| Revenue Growth | 13.65 | ★ 20.12 |
| 52 Week Low | $10.38 | $144.75 |
| 52 Week High | $30.61 | $210.50 |
Technical Indicators
Market Signals| Indicator | XNCR | HCI |
|---|---|---|
| Relative Strength Index (RSI) | 51.52 | 38.03 |
| Support Level | $23.36 | $172.50 |
| Resistance Level | $30.61 | $182.10 |
| Average True Range (ATR) | 1.03 | 3.83 |
| MACD | -0.09 | -1.20 |
| Stochastic Oscillator | 55.23 | 17.66 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
About HCI HCI Group Inc.
HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property & Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap). Both HCPCI and TypTap are authorized to underwrite various homeowners' property and casualty insurance products and allied lines business in the state of Florida and other states. The operating segments of the group are insurance operations, TypTap Group, reciprocal exchange operations, real estate operations, and corporate and other. It derives key revenue from the HCPCI Insurance operation segment.